Inspired by George and Hwang: 52-Week High Momentum
NO EDGENearness to the 52-week high forecasts returns better than past returns, and its gains do not reverse later; the authors attribute this to investors anchoring on the 52-week high when judging news.
How this run differs from the source: Many names tie at a new 52-week high, so the 20 held are partly picked in ticker order; the paper holds the top 30% long-short.
| THE STRATEGY | $SPXTR BUY & HOLD | |
|---|---|---|
| CAGR | -0.3% | 9.3% |
| Sharpe ratio | 0.05 | 0.66 |
| Max drawdown | -55.9% | -50.9% |
// GROWTH OF $1, LOG SCALE
Out-of-sample (from the split): CAGR -0.2% against 14.0% for the benchmark; Sharpe 0.05 in-sample, 0.04 out-of-sample.
After 25 bps of trading costs: -5.6% a year. BELOW RANDOM
// DECADE BY DECADE
| ERA | STRATEGY | BENCHMARK |
|---|---|---|
| 1990s | 4.0% | 20.9% |
| 2000s | -3.2% | -0.8% |
| 2010s | -0.1% | 14.0% |
| 2020s | 2.8% | 15.2% |
// YEAR BY YEAR, LOSING YEARS IN RED
Losing years: 1999 (-2.1%), 2001 (-0.7%), 2002 (-10.3%), 2004 (-8.8%), 2005 (-8.1%), 2006 (-5.3%), 2007 (-0.1%), 2008 (-33.1%), 2011 (-11.9%), 2015 (-9.0%), 2016 (-9.8%), 2018 (-11.8%), 2021 (-5.4%), 2022 (-12.1%), 2023 (-10.7%), 2026 (-1.4%). Each cell: the strategy, then the benchmark below it. * a part year.
// THE IDEA, AS PUBLISHED
George & Hwang (2004), Journal of Finance · 2004
- Rank stocks by current price divided by the highest price of the past 12 months
- Buy the top 30 percent (nearest the high), sell the bottom 30 percent, equal-weighted
- Hold 6 months in overlapping monthly cohorts
A real computation on the QuantGPT warehouse, walk-forward. A study across the whole market includes only part of the companies that later delisted from 1998 (survivors only before); a study on your own list of tickers is not affected. Gross returns, no costs except where stated. Past performance is not a promise. Findings, not advice. COMPUTED 2026-11-07 08:42 ON THE QUANTGPT WAREHOUSE. COMPANIES THAT LATER DELISTED ARE ONLY PARTLY IN THIS UNIVERSE (A FIX IS IN PROGRESS), SO THE RESULT LEANS TOWARD SURVIVORS. FUNDAMENTALS BY FILING DATE. NOT INVESTMENT ADVICE. PRIVACY